ENvue Medical, Inc. FEED
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -17.66% | -18.07% | -0.20% | -18.41% | -30.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.66% | -18.07% | -0.20% | -18.41% | -30.66% |
| Cost of Revenue | 52.80% | 69.22% | 128.57% | 41.38% | 32.97% |
| Gross Profit | -166.93% | -122.34% | -89.85% | -58.92% | -65.56% |
| SG&A Expenses | 97.19% | 143.21% | 141.14% | 108.67% | 68.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.97% | 109.55% | 132.70% | 107.53% | 86.72% |
| Operating Income | -84.77% | -179.37% | -227.61% | -269.81% | -262.38% |
| Income Before Tax | -161.59% | -311.61% | -401.68% | -117.08% | -193.34% |
| Income Tax Expenses | -515.29% | -1,170.37% | -1,715.79% | 368.00% | 240.00% |
| Earnings from Continuing Operations | -154.63% | -303.59% | -390.82% | -119.11% | -193.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -154.63% | -303.59% | -390.82% | -119.11% | -193.75% |
| EBIT | -84.77% | -179.37% | -227.61% | -269.81% | -262.38% |
| EBITDA | -81.62% | -157.82% | -202.63% | -244.89% | -245.54% |
| EPS Basic | -88.96% | -98.38% | -150.97% | -154.51% | -- |
| Normalized Basic EPS | 72.06% | -196.29% | -163.83% | -109.09% | -- |
| EPS Diluted | -88.96% | -98.38% | -150.97% | -154.51% | -- |
| Normalized Diluted EPS | 72.06% | -196.29% | -163.83% | -109.09% | -- |
| Average Basic Shares Outstanding | 1,389.81% | 1,941.88% | 770.51% | 378.21% | -- |
| Average Diluted Shares Outstanding | 759.40% | 580.63% | 385.26% | 578.21% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |